Research Paper Volume 16, Issue 5 pp 4169—4190
RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma
Figure 9. (A–C) Drugs with significantly different IC50 values between high and low RAB22A groups.
Figure 9. (A–C) Drugs with significantly different IC50 values between high and low RAB22A groups.